Moderna’s Shares Plummet After Cancer-Vaccine Data Shared on Social Media
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
- Velocity & Diffusion: Coverage escalated across 7 distinct news outlets with 8 published articles, achieving a live velocity of 26.
- Source Integrity: Verified strictly against primary headline reporting under zero-hallucination protocols.
"Moderna’s Shares Plummet After Cancer-Vaccine Data Shared on Social Media" developed substantial multi-source reporting across the Business sector, tracked across 7 distinct newsrooms by Newsylist.
Key reporting was led by The New York Times, CNN, Yahoo Finance and BioPharma Dive. Coverage velocity and cross-outlet momentum were measured using Newsylist open coverage telemetry.
Synthesized from multi-source international reporting and live coverage telemetry under Newsylist open intelligence methodology.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 46m ago.
Who reported it (8)
-
-
-
Moderna stock crashes as leaked melanoma data threatens its record August rally Yahoo Finance · 3h ago broke it first
-
-
-
-
-
Moderna, Merck Shares Fall After Possible Melanoma Data Leak Yahoo Finance · 4h ago broke it first
Quick answers
What drove coverage for Moderna’s Shares Plummet After Cancer-Vaccine Data Shared on Social Media?
Coverage spiked when 7 independent newsrooms published 8 verified reports during this coverage cycle.
How did Newsylist track this trend?
Newsylist monitored article arrival rates, source diversity, and cross-outlet validation in real time.
How do you expect this trend to evolve over the next 24 hours?
Cast your vote to register reader intelligence on the velocity and trajectory of this coverage.